|
Update on transfusion-related acute lung injury: an overview of its pathogenesis and management
|
|
0
|
40
|
29 de Janeiro de 2024
|
|
Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy
|
|
0
|
18
|
23 de Março de 2023
|
|
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and managementˆ
|
|
0
|
20
|
23 de Março de 2023
|
|
Heparin-Induced Thrombocytopenia
|
|
0
|
29
|
23 de Março de 2023
|
|
Trauma-induced coagulopathy
|
|
0
|
23
|
23 de Março de 2023
|
|
Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment
|
|
0
|
30
|
23 de Março de 2023
|
|
Palliative, Ethics, and End- of-Life Care Issues in the Cancer Patient
|
|
0
|
20
|
23 de Março de 2023
|
|
Oncologic Emergencies
|
|
0
|
20
|
23 de Março de 2023
|
|
Bleeding and Coagulopathies in Critical Care
|
|
0
|
63
|
23 de Março de 2023
|
|
Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
|
|
0
|
16
|
23 de Março de 2023
|
|
Kinetics of blood neutrophil and lymphocyte count in critically ill neutropenic patients with hematological malignancies
|
|
0
|
28
|
23 de Março de 2023
|
|
Critical Care for the Patient With Multiple Trauma
|
|
0
|
37
|
23 de Março de 2023
|
|
Anemia and Transfusion in Critical Care: Physiology and Management
|
|
0
|
14
|
23 de Março de 2023
|
|
Management of Acute Respiratory Failure in Patients With Hematological Malignancy
|
|
0
|
14
|
23 de Março de 2023
|
|
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|
|
0
|
28
|
23 de Março de 2023
|
|
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value
|
|
0
|
23
|
23 de Março de 2023
|
|
Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
|
|
0
|
18
|
23 de Março de 2023
|
|
Systemic Inflammatory Reaction After Thoracoscopic Talc Poudrage*
|
|
0
|
30
|
23 de Março de 2023
|
|
Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?
|
|
0
|
31
|
23 de Março de 2023
|
|
Massive Transfusion Protocols for Patients With Substantial Hemorrhage
|
|
0
|
26
|
23 de Março de 2023
|
|
Plasma exchange in the intensive care unit: a narrative review
|
|
0
|
29
|
23 de Março de 2023
|
|
Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine
|
|
0
|
17
|
23 de Março de 2023
|
|
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
|
|
0
|
15
|
23 de Março de 2023
|
|
Theories of Blood Coagulation
|
|
0
|
21
|
23 de Março de 2023
|
|
Hematology Emergencies in Adults With Critical Illness
|
|
0
|
28
|
23 de Março de 2023
|
|
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
|
|
0
|
16
|
23 de Março de 2023
|
|
Critical Care of Patients With Cancer
|
|
0
|
22
|
23 de Março de 2023
|
|
Critical Care of Hematopoietic Stem Cell Transplant Patients
|
|
0
|
15
|
23 de Março de 2023
|
|
Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer
|
|
0
|
39
|
23 de Março de 2023
|
|
Critical Care Issues in Oncological Surgery Patients
|
|
0
|
32
|
23 de Março de 2023
|